# GridAI Technologies Corp. Common Stock (GRDX)

> GridAI Technologies Corp. Common Stock (GRDX) trades at $3.16 (-8.41%) as of 7:30:05 PM EST on Nov 20, 2026, -42.44% over the past month. Market cap is $32.44M, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/grdx
Data as of: 2026-11-21T00:30:05.565Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$3.16** -0.29 (-8.41%)
As of 7:30:05 PM EST on Nov 20, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How GridAI Technologies Corp. Common Stock (GRDX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -8.41% |
| 1W | -15.51% |
| 1M | -42.44% |
| YTD | -32.19% |
| 1Y | +27.42% |
| 52-wk range | $1.87 – $6.93 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for GRDX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $3.12 – $3.56 |
| Open | $3.45 |
| Prev close | $3.45 |
| Volume | 125.15K |
| Market cap | $32.44M |
| Shares out | 8.54M |

## Valuation and profitability ratios

Valuation and profitability ratios for GridAI Technologies Corp. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 163.46 |
| P/B | 2.96 |
| P/FCF | — |
| ROE | -207.0% |
| ROA | -59.7% |
| Debt/Equity | 0.17 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[GridAI Technologies Corp. Common Stock (GRDX) insider trading](https://massive.com/quote/grdx/insider-trading.md): open-market Form 4 buys and sells by GridAI Technologies Corp. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events GridAI Technologies Corp. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 17, 2026 · Acquisition agreement
  “On November 12, 2026, GridAI Technologies Corp. entered into a Share Exchange Agreement pursuant to which the Sellers will transfer to the Company all of the issued and outstanding membership units of Pronghorn in exchange for shares of Common Stock and Series I Convertible Preferred Stock. Upon closing, Pronghorn will become a wholly owned subsidiary of the Company.”
- Oct 30, 2026 · Equity compensation grant
  ““Subject to the terms of the Company's equity incentive plan ... the Company will grant Ms. Skowron ... up to 250,000 restricted stock units (‘RSUs’),” with specified vesting dates and accelerated vesting upon a Change of Control.”
- Oct 28, 2026 · Private placement
  “On October 22, 2026, GridAI Technologies Corp. entered into a securities purchase agreement pursuant to which the Company agreed to sell to the Purchasers in private placements an aggregate of (i) pre-funded warrants to purchase up to an aggregate of 462,365 shares of common stock and (ii) common stock purchase warrants to purchase up to an aggregate of 462,365 shares of common stock for gross proceeds to the Company of approximately $2,150,000.”
- Oct 23, 2026 · Director departure
  “On October 19, 2026, Manpreet Uppal notified GridAI Technologies Corp. (the "Company") of his resignation as a member of the Board of Directors of the Company (the "Board"), and from all committees of the Board on which he served, effective as of October 19, 2026. Mr. Uppal's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
- Jul 6, 2026 · Private placement
  “GridAI Technologies Corp. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with the purchasers identified therein pursuant to which the Company agreed to sell to the Purchasers in private placements an aggregate of (i) 664,598 shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 1,187,325 shares of common stock (the "Pre-Funded Warrants") and (iii) common stock purchase warrants to purchase up to an aggregate of 1,851,923 shares of common stock (the "Common Warrants") for gross proceeds to the Company of approximately $8,500,000.”

## Dividend history and stock splits

GridAI Technologies Corp. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-3 · Aug 18, 2025
- 1-for-1000 · Sep 23, 2005

## GRDX short interest

How heavily GRDX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 30.49K |
| Avg volume | 116.64K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## GRDX news

The latest news and headlines about GridAI Technologies Corp. Common Stock (GRDX).

- [GridAI Technologies Signs Definitive Agreement to Acquire Pronghorn Resources, Establishing Major Wyoming Owned-Natural Gas and Multi-Gigawatt AI Power Infrastructure Platform Targeting Initial Power Delivery in 2027](https://www.globenewswire.com/news-release/2026/11/13/3402604/0/en/gridai-technologies-signs-definitive-agreement-to-acquire-pronghorn-resources-establishing-major-wyoming-owned-natural-gas-and-multi-gigawatt-ai-power-infrastructure-platform-targe.html) · GlobeNewswire Inc. · Nov 13, 2026 · positive sentiment

## About GridAI Technologies Corp. Common Stock

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ELECTRIC & OTHER SERVICES COMBINED |
| Employees | 2 |
| Listed | Oct 11, 2016 |

[Company website](https://www.enterothera.com)

## FAQ

### What is the GridAI Technologies Corp. Common Stock (GRDX) stock price today?

GridAI Technologies Corp. Common Stock (GRDX) is trading at $3.16 (-8.41% on the day) as of 7:30:05 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is GridAI Technologies Corp. Common Stock?

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.

### What is the short interest in GRDX?

As of Oct 30, 2026, GRDX has 30.49K shares short and 1.0 days to cover.

### What exchange is GRDX listed on?

GridAI Technologies Corp. Common Stock (GRDX) trades on Nasdaq in USD, in the ELECTRIC & OTHER SERVICES COMBINED industry.

## Live data

Prices here are 15-minute delayed. For real-time GRDX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=GRDX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [GridAI Technologies Corp. Common Stock (GRDX) insider trading](https://massive.com/quote/grdx/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
